CVE-2024-0770: What You Need to Know

This CVE-2024-0770 involves a vulnerability found in the European Chemicals Agency IUCLID 7.10.3 on Windows, specifically in the Desktop Installer component. The issue is related to incorrect default permissions, classified as critical.

Understanding CVE-2024-0770

This vulnerability in European Chemicals Agency's IUCLID software version 7.10.3 poses a security risk due to the incorrect default permissions associated with the file iuclid6.exe in the Desktop Installer component.

What is CVE-2024-0770?

The vulnerability CVE-2024-0770 relates to an unspecified function of the file iuclid6.exe within the Desktop Installer module of European Chemicals Agency's IUCLID version 7.10.3. Exploitation of this vulnerability can lead to the manipulation of default permissions, posing a risk when accessed locally.

The Impact of CVE-2024-0770

With a CVSSv3 base score of 4.4, this medium-severity vulnerability could allow an attacker to manipulate default permissions, potentially leading to unauthorized access or other security breaches within the affected system.

Technical Details of CVE-2024-0770

The following technical aspects of CVE-2024-0770 provide insights into the vulnerability's nature and implications:

Vulnerability Description

The vulnerability in European Chemicals Agency IUCLID 7.10.3 pertains to incorrect default permissions associated with the file iuclid6.exe in the Desktop Installer component. It is crucial to address this issue promptly to prevent any unauthorized access or exploitation.

Affected Systems and Versions

The affected system identified in this CVE is the European Chemicals Agency's IUCLID version 7.10.3 on Windows. Specifically, the Desktop Installer module is susceptible to this vulnerability.

Exploitation Mechanism

Exploiting the vulnerability requires local access to the system running IUCLID version 7.10.3. By manipulating unknown data within the iuclid6.exe file, attackers can exploit the incorrect default permissions, leading to potential security risks.

Mitigation and Prevention

To mitigate the risks associated with CVE-2024-0770, it is essential to take immediate steps and implement long-term security practices to safeguard the affected systems from potential exploitation.

Immediate Steps to Take

Update the affected IUCLID software to a patched version that addresses the vulnerability.
Monitor system logs and access permissions to detect any unauthorized changes related to default permissions.

Long-Term Security Practices

Implement a robust security policy that includes regular software updates and patches.
Conduct regular security audits and vulnerability assessments to identify and address potential risks proactively.

Patching and Updates

Ensure timely installation of patches and updates released by the European Chemicals Agency for the IUCLID software to address the incorrect default permissions vulnerability and enhance overall system security.